Anton Gusev

Anton Gusev joined Neuraptive in March 2022 as a Regulatory and CMC Consultant and brings with him over 16 years of global regulatory affairs and quality assurance experience for novel pharmaceutical products, medical devices and combination products. Anton has strong early, late, and post-approval regulatory and CMC experience with multiple regulatory submissions and approval of NDAs (US) and MAAs (EU and ex-EU markets). Anton`s areas of expertise include regulatory affairs, quality assurance, pharmacovigilance, healthcare compliance and GMP audits and inspections.

Anton earned his Doctor of Pharmacy (PharmD) in Medicinal and Pharmaceutical Chemistry and his Bachelor of Business Administration and Management degree.